Ryan Nipp to alpha-Fetoproteins
This is a "connection" page, showing publications Ryan Nipp has written about alpha-Fetoproteins.
Connection Strength
0.045
-
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials. ESMO Open. 2020 08; 5(4).
Score: 0.045